Page last updated: 2024-10-29

amrinone and Edema, Pulmonary

amrinone has been researched along with Edema, Pulmonary in 2 studies

Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakatsuka, M1
Gehr, LC1
Glauser, FL1
Takeda, S1
Takano, T1
Nakanishi, K1
Nejima, J1
Takayama, M1
Kim, C1
Ogawa, R1

Trials

1 trial available for amrinone and Edema, Pulmonary

ArticleYear
Amrinone improves lung compliance in patients receiving mechanical ventilation for cardiogenic pulmonary edema.
    Acta anaesthesiologica Scandinavica, 1997, Volume: 41, Issue:5

    Topics: Aged; Amrinone; Blood Gas Analysis; Cyclic AMP; Cyclic GMP; Female; Heart Failure; Hemodynamics; Hum

1997

Other Studies

1 other study available for amrinone and Edema, Pulmonary

ArticleYear
The effects of amrinone and calcium chloride on pulmonary vasculature and biventricular function in ethchlorvynol-induced lung injury in sheep.
    Acta anaesthesiologica Scandinavica, 1993, Volume: 37, Issue:2

    Topics: Amrinone; Animals; Blood Pressure; Calcium Chloride; Cardiac Output; Cardiac Volume; Ethchlorvynol;

1993